China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket, as the success rate of new drug development is extremely low and the costs are ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Commentary: To win the biotech battle, we don’t need entirely new strategies. We just need to avoid self-destructive policies ...

The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at scale.